biotech

Companies October 31, 2026

Regeneron third-quarter revenue rose 36% to $5.1 billion

Regeneron reported third-quarter 2026 revenue of $5.12 billion, up 36% from a year earlier, and non-GAAP earnings of $20.07 a share, helped by higher Sanofi collaboration revenue.